 BURLINGTON, Mass., Dec. 07, 2020 GLOBE NEWSWIRE -- Flexion Therapeutics, Inc. Nasdaq:FLXN announced today that Michael Clayman, M.D., President and Chief Executive Officer, will participate in an analyst-led fireside chat at the Needham Virtual Epilepsy and Pain Specialty CNS Therapeutics Conference. The virtual fireside chat is scheduled to begin at 2:15 p.m. ET on Friday, December 11, 2020. 